Page last updated: 2024-10-24

opioid receptor binding

Definition

Target type: molecularfunction

Binding to an opioid receptor. [GOC:nln]

Opioid receptors are a class of G protein-coupled receptors (GPCRs) that are activated by opioid ligands, such as morphine, heroin, and endorphins. Opioid receptor binding initiates a signaling cascade that leads to a variety of cellular responses, including analgesia, euphoria, respiratory depression, and constipation. The molecular function of opioid receptor binding involves the following steps: 1) Binding of an opioid ligand to the receptor. Opioid ligands bind to the receptor's transmembrane domain, which is composed of seven alpha helices. This binding event causes a conformational change in the receptor, which activates its intracellular signaling pathways. 2) Activation of G proteins. The activated opioid receptor interacts with a heterotrimeric G protein, which is composed of alpha, beta, and gamma subunits. The alpha subunit of the G protein binds to GTP (guanosine triphosphate), which causes it to dissociate from the beta and gamma subunits. 3) Activation of downstream signaling pathways. The activated alpha subunit of the G protein can then activate a variety of downstream signaling pathways, including the adenylate cyclase pathway, the mitogen-activated protein kinase (MAPK) pathway, and the phospholipase C pathway. These pathways are responsible for mediating the physiological effects of opioid receptor activation. 4) Desensitization of the receptor. Prolonged exposure to opioid ligands can lead to desensitization of the receptor, which is a process in which the receptor becomes less responsive to further stimulation. Desensitization is thought to be caused by phosphorylation of the receptor by G protein-coupled receptor kinases (GRKs). Phosphorylation of the receptor can lead to its internalization, which removes it from the cell surface. 5) Termination of signaling. The signaling cascade initiated by opioid receptor binding is eventually terminated by the hydrolysis of GTP to GDP (guanosine diphosphate) by the alpha subunit of the G protein. This hydrolysis event causes the alpha subunit to reassociate with the beta and gamma subunits, which inactivates the G protein and terminates the signaling cascade.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Proenkephalin-BA proenkephalin-B that is encoded in the genome of human. [PRO:DNx, UniProtKB:P01213]Homo sapiens (human)
Neuropeptide FF receptor 2A neuropeptide FF receptor 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q9Y5X5]Homo sapiens (human)

Compounds (6)

CompoundDefinitionClassesRoles
enkephalin, leucineEnkephalin, Leucine: One of the endogenous pentapeptides with morphine-like activity. It differs from MET-ENKEPHALIN in the LEUCINE at position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN.

Leu-enkephalin : A pentapeptide comprising L-tyrosine, glycine, glycine, L-phenylalanine and L-leucine residues joined in sequence by peptide linkages. It is an endogenous opioid peptide produced in vertebrate species, including rodents, primates and humans that results from decomposition of proenkephalin or dynorphin and exhibits antinociceptive properties.
pentapeptide;
peptide zwitterion
analgesic;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist;
neurotransmitter;
rat metabolite
bibp 3226BIBP 3226: a selective non-peptide neuropeptide Y Y1 receptor antagonist; structure given in first source; BIBP-3435 is the S-enantiomer
phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide
fmrfamideFMRFamide: A molluscan neuroactive peptide which induces a fast excitatory depolarizing response due to direct activation of amiloride-sensitive SODIUM CHANNELS. (From Nature 1995; 378(6558): 730-3)
kisspeptin-10 protein, human
RF9dipeptidekisspeptin receptor agonist;
neuropeptide FF receptor agonist;
neuropeptide FF receptor antagonist